Glaukos Corporation (GKOS)

NYSE

$167.80

$+2.39

(+1.44%)

After-Hours

Glaukos Corporation (GKOS) Live Price Chart

Last updated: ⁦2026-10-14 22:31:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Glaukos Corporation (GKOS) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $167.80, with a market capitalisation of $9.91B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $73.16 to $191.62. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$9.91B
Open	$164.94
Day's High	$191.62
Day's Low	$14.25
Previous Close	$165.50
Volume	508.41K
Average Volume	856.46K
P/E Ratio	--
52-Week High	$191.62
52-Week Low	$73.16
Dividend Yield	--
Earnings Date	--

Glaukos Corporation (GKOS) After-Hours Stock Price

Glaukos Corporation (GKOS) is trading at $167.90 in after-hours trading as of 2026-10-14 22:26:00, up 1.45% ($2.40) from the regular-session close of $165.50.

After-hours trading shows how investors are pricing GKOS after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

Glaukos Corporation (GKOS) 7-Day Stock Price Change

Over the past seven days, Glaukos Corporation (GKOS) moved from $164.01 to $167.80, representing a gain of 2.31% ($3.79).

The stock traded between $146.39 and $174.48 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 1.27 million shares, up versus the previous seven-day period, indicating higher trading activity.

GKOS 52-Week Price Position

Position in Range: 79.9%

52W Low$73.16

52W High$191.62

GKOS is currently trading at $167.80, placing it 79.9% of the way from its 52-week low of $73.16 to its 52-week high of $191.62. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Glaukos Corporation (GKOS)?

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Glaukos Corporation Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	1094
Exchange	NYSE
Company Website	https://www.glaukos.com

How to Buy Glaukos Corporation (GKOS) Stock on MEXC

Eligible investors can buy real shares of Glaukos Corporation (GKOS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GKOS and Place Your Order

Open the RealStocks trading page and search for GKOS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Glaukos Corporation (GKOS) stock price today?

Glaukos Corporation (GKOS) is currently trading at $ 167.80, up 1.39% ($2.30) from the previous close of $ 165.50. Intraday prices update in real time during regular trading hours.

2.Is GKOS stock going up or down today?

As of 2026-10-14 22:26:00, GKOS is trading at $ 167.80, up 1.39% ($2.30) from its previous close of $ 165.50. The stock has traded between $ 14.25 and $ 191.62 during today’s regular session. Past price movements do not guarantee future results.

3.What is GKOS pre-market price?

As of 2026-10-14 22:26:00, GKOS is trading at $ 165.25 in pre-market trading, down 0.15% ($0.25) from the previous close of $ 165.50. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GKOS after-hours price?

As of 2026-10-14 22:26:00, GKOS is trading at $ 167.90 in after-hours trading, up 1.45% ($2.40) from the regular-session close of $ 165.50. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GKOS stock trading now?

GKOS trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GKOS sit relative to its 52-week high and low?

Over the past 52 weeks, GKOS has traded between a low of $ 73.16 and a high of $ 191.62. At $ 167.80, the stock is positioned 79.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Glaukos Corporation in?

Glaukos Corporation (GKOS) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Glaukos Corporation's market capitalisation and where is it listed?

Glaukos Corporation is listed on the NYSE exchange with a market capitalisation of $ 9.91B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GKOS valued in terms of P/E ratio and EPS?

GKOS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.19. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Glaukos Corporation pay a dividend?

Glaukos Corporation pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.